Neurology
Schizophrenia’s Missing Symptoms Move Onto the Phone
A Phase III randomised trial found that a smartphone therapeutic improved motivation and pleasure-related negative symptoms of schizophrenia. The significance is not that an app replaces psychiatry. It is that psychiatry may finally be treating what medication often leaves behind.
Sanfilippo’s Approval Path Is Being Built Before Approval
Parkinson’s Gets a Cleaner Dopamine Bet
Myasthenia Care Cannot Wait for Crisis
Duchenne’s Cell Therapy Gets More Time, Not Certainty
Alzheimer’s Blood Tests Are Becoming the Gate
Tourette Care Has Waited Too Long
Narcolepsy Gets Treated at the Cause
Myositis Finally Gets a Targeted Signal
MS Prevention Is Still Too Passive
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
Diseases in Neurology
Explore disease data and country profiles on the IPM Alliance platform.
Explore diseases